CANADA LIFE ASSURANCE Co
InsurancePosition in CLDX — Celldex Therapeutics, Inc.
CIK 1046192
WINNIPEG, A2
Position in CLDX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$436,324
+$235,283 QoQ
Shares Held
11,726
+85.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#151
of 252 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $333,087,992 across 79 Biotechnology names. CLDX ranks #44 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
182,365 | $90,586,166 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
86,761 | $54,098,953 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
69,102 | $20,801,775 | |
| 4 | INCY |
Incyte Corp
|
126,229 | $14,309,319 | |
| 5 | ARGX |
Argenx SE
|
14,868 | $13,794,084 | |
| 6 | MRNA |
Moderna, Inc.
|
152,228 | $10,660,526 | |
| 7 | RPRX |
Royalty Pharma plc
|
185,316 | $10,390,668 | |
| 8 | EXEL |
Exelixis, Inc.
|
155,922 | $8,483,716 |
All Filings in CLDX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $436,324 | 11,726 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $201,041 | 6,338 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $172,140 | 6,338 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $163,964 | 6,338 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $128,978 | 6,338 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $115,034 | 6,338 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $160,161 | 6,338 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $215,428 | 6,338 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $503,965 | 13,617 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $191,802 | 4,570 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $143,370 | 3,615 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $99,484 | 3,615 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $57,714 | 1,701 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $61,201 | 1,701 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $92,259 | 2,070 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $58,187 | 2,070 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $55,807 | 2,070 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $70,504 | 2,070 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $79,984 | 2,070 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $111,759 | 2,070 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $85,272 | 2,550 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $52,530 | 2,550 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $44,676 | 2,550 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||